Derek Hicks
Corporate Officer/Principal bij INTELLIA THERAPEUTICS, INC.
Vermogen: 2 M $ op 31-03-2024
Profiel
Derek Hicks is currently the Chief Business Officer & Executive Vice President at Intellia Therapeutics, Inc. Prior to this, he worked as the Head of Business Development at Spark Therapeutics, Inc. from 2020 to 2021.
Hicks has an undergraduate and graduate degree from the University of Connecticut and an MBA from the Kelley School of Business.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 01-03-2024 | 66 380 ( 0.07% ) | 2 M $ | 31-03-2024 |
Actieve functies van Derek Hicks
| Bedrijven | Functie | Begin |
|---|---|---|
| INTELLIA THERAPEUTICS, INC. | Corporate Officer/Principal | 20-12-2021 |
Eerdere bekende functies van Derek Hicks
| Bedrijven | Functie | Einde |
|---|---|---|
| SPARK THERAPEUTICS, INC. | Corporate Officer/Principal | 01-12-2021 |
Opleiding van Derek Hicks
| University of Connecticut | Graduate Degree |
| Kelley School of Business | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| INTELLIA THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Spark Therapeutics, Inc.
 Spark Therapeutics, Inc. BiotechnologyHealth Technology Spark Therapeutics, Inc. engages in the research, development, and commercialization of gene therapies. Its product portfolio intends to treat inherited retinal sickness, liver-mediated, and neurodegenerative diseases. The company was founded by Jean Bennett, Beverly Davidson, Katherine A. High, Jeffrey D. Marrazzo, J. Fraser Wright, and Jennifer Wellman on March 13, 2013 and is headquartered in Philadelphia, PA. | Health Technology |
